Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 15,000 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 26, 2026

On Jun 25, 2026, Burrows Scott L (Chief Financial Officer) sold 15,000 Spyre Therapeutics, Inc. shares at an average US$87.13 for US$1.31M, leaving 97,994 shares. Filed Jun 26, 2026 (Form 4).

Sold
15,000 shares
Price
US$87.13 average (US$87.12 to US$87.14)
Value
US$1.31M
Holding after
97,994 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockOption exercise15,000US$14.50112,994Direct
Jun 25, 2026Common StockSale5,000US$87.12107,994Direct
Jun 25, 2026Common StockSale10,000US$87.1497,994Direct

Source

View original at SEC

Related